Nyumbani › Multiple Myeloma › Alabama › Birmingham
Majaribio ya kliniki ya Multiple Myeloma katika Birmingham, AL
Masomo 18 ya Multiple Myeloma yanatafuta washiriki katika vituo vya Birmingham na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
InaajiriHatua 1/2
- University of Alabama At Birmingham Hospital, Birmingham
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
InaajiriHatua 3
- Alabama Oncology, Birmingham
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
InaajiriHatua 2
- University of Alabama Birmingham, Birmingham
A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma
InaajiriHatua 1/2
- University of Alabama at Birmingham Hospital, Birmingham
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
InaajiriHatua 2
- University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
InaajiriHatua 3
- University of Alabama at Birmingham, Birmingham
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
InaajiriHatua 2
- University of Alabama at Birmingham, Birmingham
A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma
InaajiriHatua 1/2
- University of Alabama at Birmingham, Birmingham
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
InaajiriHatua 1/2
- Research Site, Birmingham
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
InaajiriHatua 1
- University of Alabama at Birmingham, Birmingham
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
InaajiriHatua 2
- University of Alabama at Birmingham, Birmingham
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
InaajiriHatua 1
- University of Alabama at Birmingham, Birmingham
Study of BMS-986453 in Newly Diagnosed Multiple Myeloma
InaajiriHatua 1
- University of Alabama at Birmingham, Birmingham
Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)
InaajiriHatua 2
- University of Alabama at Birmingham, Birmingham
Prehabilitation Feasibility Among Older Adults Undergoing Transplantation
Inaajiri
- Kirklin Clinic of UAB Hospital, Birmingham
Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry
InaajiriUtafiti wa uchunguzi
- Kirklin Clinic of UAB Hospital, Birmingham
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
InaajiriHatua 1
- University of Alabama at Birmingham, Birmingham
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
InaajiriHatua 1/2
- UAB Comprehensive Cancer Center, Birmingham
Majaribio ya Multiple Myeloma katika miji mingine
- New York City, NYUtafiti 60
- Boston, MAUtafiti 42
- Atlanta, GAUtafiti 41
- Houston, TXUtafiti 38
- Durham, NCUtafiti 37
- Nashville, TNUtafiti 32
- Denver, COUtafiti 27
- Rochester, MNUtafiti 24
- St. Louis, MOUtafiti 24
- Columbus, OHUtafiti 24
- Baldwin Park, CAUtafiti 23
- Chicago, ILUtafiti 22
Masomo mengine katika Birmingham
- Saratani (aina zote)Utafiti 30
- Saratani ya MatitiUtafiti 24
- UnenepuUtafiti 23
- Kansari ya MayaiUtafiti 23
- Saratani ya Mapafu Isiyo na Selu NdogoUtafiti 22
- Leukemia ya Myeloid ya GhaflaUtafiti 21
- COPDUtafiti 17
- Magonjwa ya Moyo na Mishipa ya DamuUtafiti 17
- Uzito Kupita KiasiUtafiti 16
- Saratani ya EndometrialUtafiti 16
- Kisukari cha Aina ya 2Utafiti 16
- Fibrosis ya KiziziUtafiti 16
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.